Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Cetuximab + Chemoradiotherapy (CRT) & Esophageal adenocarcinoma (EAC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

This regimen demonstrated promising activity. Toxicity was signiﬁcant, with seven study-related deaths leading to closure after stage 1. All postoperative deaths were due to acute respiratory distress syndrome (ARDS). This regimen is not recommended.
Gibson et al. 2020…

References (Sources)

Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5‐Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG‐ACRIN Cancer Research Group (E2205)
Gibson et al. 2020

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Cetuximab + Chemoradiotherapy (CRT) & Esophageal adenocarcinoma (EAC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat